Impact of population admixture on the distribution of the CYP3A5*3 polymorphism.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Pharmacogenomics (London)

• Publication date

  2007-11-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/14622416.8.10.1299PMID 17979504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Lego System for Conditional Inference ✯

  2019cited by this paper
• CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir

  2007cited by this paper
• Pharmacogenomics in admixed populations.

  2007cited by this paper
• Admixture in North America

  2007cited by this paper
• CYP3A5 Genotype Markedly Influences the Pharmacokinetics of Tacrolimus and Sirolimus in Kidney Transplant Recipients

  2007cited by this paper
• CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure

  2007cited by this paper
• Genetic ancestry, population sub-structure, and cardiovascular disease-related traits among African-American participants in the CARDIA Study

  2007cited by this paper
• Self-reported skin color, genomic ancestry and the distribution of GST polymorphisms

  2007cited by this paper
• Pharmacogenomics in the Americas: the impact of genetic admixture.

  2006cited by this paper
• The Genetic Structure of Human Populations Studied Through Short Insertion‐Deletion Polymorphisms

  2006cited by this paper
• The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population.

  2006cited by this paper
• A tutorial on statistical methods for population association studies

  2006cited by this paper
• Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects

  2006cited by this paper
• Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients.

  2006cited by this paper
• Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients

  2006cited by this paper
• CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS

  2005cited by this paper
• Examining Population Stratification via Individual Ancestry Estimates versus Self-Reported Race

  2005cited by this paper
• The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid‐lowering efficacy and safety of simvastatin treatment

  2005cited by this paper
• CYP3A4 and CYP3A5 genotyping by Pyrosequencing

  2005cited by this paper
• Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus.

  2005cited by this paper
• Serum angiotensin converting enzyme activity association with the I/D polymorphism in an ethnically admixtured population.

  2005cited by this paper
• Detection of CYP2C9*5 in a White Brazilian Subject

  2005cited by this paper
• Implications of correlations between skin color and genetic ancestry for biomedical research

  2004cited by this paper
• CYP3A4, CYP3A5, and CYP3A43 Genotypes and Haplotypes in the Etiology and Severity of Prostate Cancer

  2004cited by this paper
• CYP3A variation and the evolution of salt-sensitivity variants.

  2004influential reference
• Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.

  2003cited by this paper
• Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis

  2003cited by this paper
• Thiopurine methyltransferase polymorphisms in a Brazilian population

  2003cited by this paper
• Genetic contribution to variable human CYP3A-mediated metabolism.

  2002cited by this paper
• Color and genomic ancestry in Brazilians

  2002cited by this paper
• Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population.

  2002cited by this paper
• Polymorphism analysis of CYP3A5 in myeloid leukemia.

  2002cited by this paper
• The Evolution and Genetics of Latin American Populations

  2001influential reference
• The genetic determinants of the CYP3A5 polymorphism.

  2001cited by this paper
• Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

  2001influential reference
• Inference of population structure using multilocus genotype data.

  2000cited by this paper

• Single-Nucleotide Polymorphisms Associated with Mercury Levels and Neurological Symptoms: An Overview

  2024cites this paper
• Genetic structure of pharmacogenetic biomarkers in Brazil inferred from a systematic review and population-based cohorts: a RIBEF/EPIGEN-Brazil initiative

  2018cites this paper
• Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients

  2017cites this paper
• Pharmacogenetics in Central American healthy volunteers: interethnic variability

  2015cites this paper
• CYP2D6, CYP3A5, and CYP3A4 gene polymorphisms in Russian, Tatar, and Bashkir populations

  2015cites this paper
• The effect of CYP3A5 polymorphism on cyclosporine plasma level in Egyptian renal transplant recipients

  2015cites this paper
• Association of Genetic Variants with Self-Assessed Color Categories in Brazilians

  2014cites this paper
• Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population

  2014cites this paper
• Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population

  2014cites this paper
• Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians

  2014cites this paper
• Life experience and demographic influences on cognitive function in older adults.

  2014cites this paper
• Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients.

  2014cites this paper
• Pharmacogenomic implications of population admixture: Brazil as a model case.

  2014cites this paper
• CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population

  2014cites this paper
• Pharmacogenetics of drug metabolizing enzymes in Brazilian populations

  2014cites this paper
• Pharmacogenomics in Brazil

  2014cites this paper
• Pharmacogenomics of warfarin in populations of African descent

  2013cites this paper
• Population Heterogeneity and Genomic Admixture: Relevance for GlobalPharmacogenetics

  2013cites this paper
• Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin

  2012cites this paper
• Frequency of the most common CYP3A5 polymorphisms in the healthy population of the Republic of Macedonia

  2012cites this paper
• Pharmacogenomic Applications in the Developing World: The American Continent

  2012cites this paper
• Correlations of CTLA‐4 gene polymorphisms and hepatitis C chronic infection

  2012cites this paper
• Differentiation of African Components of Ancestry to Stratify Groups in a Case-Control Study of a Brazilian Urban Population

  2012influential citation
• Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c.388A>G Variant Is Determinant of Increased Atorvastatin Response

  2011cites this paper
• The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than Expected

  2011cites this paper
• Population analysis of vitamin D receptor polymorphisms and the role of genetic ancestry in an admixed population

  2011influential citation
• Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.

  2011cites this paper
• Pharmacogenetics in the Brazilian Population

  2010cites this paper
• Randomized crossover study to assess the inter‐ and intrasubject variability of morning mycophenolic acid concentrations from enteric‐coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients

  2010cites this paper
• Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation

  2010cites this paper
• The Emerging Role of Admixture in the Pharmacogenetics of Puerto Rican Hispanics.

  2010cites this paper
• Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin.

  2010cites this paper
• VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications.

  2010cites this paper
• Association of complement factor H Y402H polymorphism and age‐related macular degeneration in Brazilian patients

  2010cites this paper
• Statin regulation of CYP 3 A 4 and CYP 3 A 5 expression CYP 3 A 4 & CYP 3 A 5 : function & variants

  2009cites this paper
• Statin regulation of CYP3A4 and CYP3A5 expression.

  2009cites this paper
• Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients ReseaRch

  2009cites this paper
• FARMACOGENÉTICA DO ANTICOAGULANTE ORAL WARFARINA E O IMPACTO DE POLIMORFISMOS NOS GENES CYP2C9 E VKORC1

  2009cites this paper
• Pharmacogenetics of Human Carbonyl Reductase 1 (CBR1) in Livers from Black and White Donors

  2009cites this paper
• Ethnic differences in drug therapy: a pharmacogenomics perspective

  2008cites this paper
• Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients

  2008cites this paper
• CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia.

  2008cites this paper
• Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure

  2008cites this paper
• Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture.

  2008cites this paper
• CYP3A5 Genotype Has No Impact on Plasma Trough Concentrations of Lopinavir and Ritonavir in HIV‐infected Subjects

  2008cites this paper